In the BioHarmony Drug Report Database

"Preview" Icon

Propafenone

Rythmol, Rythmol Sr (propafenone) is a small molecule pharmaceutical. Propafenone was first approved as Rythmol on 1989-11-27. It is used to treat atrial fibrillation, cardiac arrhythmias, and supraventricular tachycardia in the USA. The pharmaceutical is active against beta-1 adrenergic receptor. In addition, it is known to target potassium voltage-gated channel subfamily A member 5 and beta-2 adrenergic receptor.

 

Trade Name

 

Rythmol, Rythmol Sr
 

Common Name

 

propafenone
 

ChEMBL ID

 

CHEMBL631
 

Indication

 

atrial fibrillation, cardiac arrhythmias, supraventricular tachycardia
 

Drug Class

 

Antiarrhythmics (propafenone derivatives)

Image (chem structure or protein)

Propafenone structure rendering